233 related articles for article (PubMed ID: 11086857)
1. Developments in preclinical AIDS vaccine efficacy models.
Bogers WM; Cheng-Mayer C; Montelaro RC
AIDS; 2000; 14 Suppl 3():S141-51. PubMed ID: 11086857
[No Abstract] [Full Text] [Related]
2. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
3. Feline immunodeficiency virus as a model for AIDS vaccination.
Jarrett O; Yamamoto JK; Neil JC
AIDS; 1990; 4 Suppl 1():S163-5. PubMed ID: 1967108
[No Abstract] [Full Text] [Related]
4. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
5. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
Cohen J
Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
[No Abstract] [Full Text] [Related]
6. AIDS vaccine models: challenging challenge viruses.
Feinberg MB; Moore JP
Nat Med; 2002 Mar; 8(3):207-10. PubMed ID: 11875482
[No Abstract] [Full Text] [Related]
7. Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine.
Yamamoto JK; Pu R; Sato E; Hohdatsu T
AIDS; 2007 Mar; 21(5):547-63. PubMed ID: 17314517
[No Abstract] [Full Text] [Related]
8. Prospects for an AIDS vaccine.
Schultz AM; Koff WC
Semin Immunol; 1990 Sep; 2(5):351-9. PubMed ID: 2134018
[TBL] [Abstract][Full Text] [Related]
9. 25 years of HIV research! ... and what about a vaccine?
Appay V
Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
[TBL] [Abstract][Full Text] [Related]
10. Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections.
Overbaugh J; Luciw PA; Hoover EA
AIDS; 1997; 11 Suppl A():S47-54. PubMed ID: 9451965
[No Abstract] [Full Text] [Related]
11. Vaccines. Monkey puzzles.
Cohen J
Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
[No Abstract] [Full Text] [Related]
12. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
Bhardwaj N; Walker BD
Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
[No Abstract] [Full Text] [Related]
13. Immunization for long-term protection against AIDS using the macaque model.
Kumar A; Narayan O
Virology; 2001 Jun; 285(1):1-5. PubMed ID: 11414799
[No Abstract] [Full Text] [Related]
14. Scientists to pursue AIDS vaccine based on EIA model.
J Am Vet Med Assoc; 1997 Aug; 211(3):266. PubMed ID: 9262653
[No Abstract] [Full Text] [Related]
15. HIV vaccine design: insights from live attenuated SIV vaccines.
Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
[TBL] [Abstract][Full Text] [Related]
16. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
17. Is AIDS vaccine research at a turning point?
Levy JP
J Hum Virol; 2000; 3(2):83-7. PubMed ID: 10850894
[TBL] [Abstract][Full Text] [Related]
18. New gene-based approaches for an AIDS vaccine.
Puaux AL; Michel ML
Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):357-72. PubMed ID: 12818622
[TBL] [Abstract][Full Text] [Related]
19. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
Yang OO
Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
[No Abstract] [Full Text] [Related]
20. Progress in vaccines against AIDS.
Bolognesi DP
Science; 1989 Dec; 246(4935):1233-4. PubMed ID: 2555922
[No Abstract] [Full Text] [Related]
[Next] [New Search]